MRI and Imaging Findings in Corticobasal Syndrome

Overview

Neuroimaging plays a crucial role in the diagnosis and characterization of corticobasal syndrome (CBS). Structural and functional imaging can help differentiate CBS from other parkinsonian syndromes and may provide insights into the underlying pathology. The asymmetric frontoparietal atrophy pattern is a hallmark feature that distinguishes CBS from [Parkinson's disease](/diseases/parkinsons-disease) and [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy).[^brain]

Structural MRI Findings

Cortical Atrophy

Overview

Neuroimaging plays a crucial role in the diagnosis and characterization of corticobasal syndrome (CBS). Structural and functional imaging can help differentiate CBS from other parkinsonian syndromes and may provide insights into the underlying pathology. The asymmetric frontoparietal atrophy pattern is a hallmark feature that distinguishes CBS from [Parkinson's disease](/diseases/parkinsons-disease) and [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy).[^brain]

Structural MRI Findings

Cortical Atrophy

• Asymmetric cortical atrophy: The hallmark imaging finding in CBS is asymmetric frontoparietal atrophy, typically more pronounced contralateral to the most affected limb[^brain]
• Parietal lobe involvement: Superior and inferior parietal lobules show significant atrophy
• Frontal lobe atrophy: Premotor cortex and supplementary motor area (SMA) are commonly affected
• Posterior temporal involvement: Superior temporal gyrus atrophy may be present
• Asymmetry index: A left-right asymmetry ratio >10% is highly suggestive of CBS

Regional Atrophy Patterns

Subcortical Changes

• Basal ganglia atrophy: Putamen and globus pallidus show volume loss
• Thalamic changes: Thalamic atrophy, particularly in the ventral lateral nucleus
• Brainstem involvement: Pontine and midbrain atrophy, though less prominent than in PSP
• Corpus callosum thinning: Especially in the posterior portions
• Red nucleus involvement: May show iron deposition in advanced cases

White Matter Changes

• Periventricular white matter hyperintensities: Subcortical white matter lesions
• Asymmetric involvement: White matter changes often correspond to cortical atrophy pattern
• Centrum semiovale: Small-vessel ischemic changes may be present
• Superior longitudinal fasciculus: Tract-specific degeneration correlates with apraxia

Advanced MRI Techniques

Diffusion Tensor Imaging (DTI)[^niccoli2022]

• Fractional anisotropy reduction: In corticospinal tracts and corpus callosum
• Mean diffusivity increases: Reflecting white matter tract degeneration
• Pattern differentiation: DTI metrics can help distinguish CBS from PSP and PD
• Regional specificity: Asymmetric FA loss in premotor and parietal regions
• Network-based analysis: Disruption of frontoparietal and basal ganglia networks

MR Spectroscopy

• N-acetylaspartate reduction: Indicating neuronal loss
• Choline elevation: Reflecting membrane turnover and gliosis
• Creatine changes: Metabolic alterations in affected regions
• Lactate peaks: May be elevated in some cases suggesting mitochondrial dysfunction

Susceptibility-Weighted Imaging (SWI)

• Iron deposition: Increased iron in basal ganglia
• Microhemorrhages: Small hemorrhagic lesions may be present
• Mineralization patterns: Distinct from other parkinsonian syndromes
• Nigrosome imaging: May show normal substantia nigra in CBS (vs. PD)

Quantitative T1 Mapping

• R1 relaxation: Reduced in cortical regions affected by atrophy
• Myelin integrity: Can assess demyelination patterns
• Longitudinal monitoring: Tracks disease progression over time

Functional Imaging

FDG-PET

• Asymmetric hypometabolism: Contralateral to the most affected side
• Parietal and frontal hypometabolism: Characteristic pattern[^lehericy2014]
• Basal ganglia hypometabolism: Including putamen and caudate
• Diagnostic utility: FDG-PET pattern helps differentiate CBS from PD and PSP
• Posterior cingulate: May show hypometabolism mimicking AD patterns
• Brainstem metabolism: Generally preserved compared to PSP

Tau PET Imaging[^boden2022]

• Fluorinated tau tracers: Show increased binding in CBS
• Regional distribution: Correlates with clinical symptoms
• Differential diagnosis: Helps distinguish CBD pathology from other causes
• 18F-Flortaucipir: Approved for tau visualization in AD, shows offtarget binding in CBS
• Emerging tracers: Novel 4R-tau selective tracers in development

Dopaminergic Imaging

• Presynaptic dopaminergic function: Reduced dopamine transporter binding
• Post-synaptic dysfunction: D2 receptor binding may be reduced
• Differential from PD: Helps rule out idiopathic Parkinson's disease
• Pattern analysis: Asymmetric loss pattern distinguishes CBS

Functional Connectivity

• Default mode network: Disruption correlates with cognitive impairment
• Motor network: Reduced connectivity between premotor and parietal regions
• Salience network: May show increased activity in early CBS

Differential Diagnosis Patterns

CBS vs. Parkinson's Disease

| Feature | CBS | PD |
|---------|-----|-----|
| Asymmetry | Marked asymmetry | Mild asymmetry |
| Cortical atrophy | Present | Absent |
| Parietal hypometabolism | Prominent | Absent |
| Dopamine response | Poor | Good |
| Cortical signs | Early | Late/Absent |
| Tremor | Less prominent | Prominent |

CBS vs. PSP

| Feature | CBS | PSP |
|---------|-----|-----|
| Midbrain atrophy | Mild-moderate | Severe (hummingbird sign) |
| Superior frontal atrophy | Less prominent | Prominent |
| Parietal involvement | Prominent | Less prominent |
| Asymmetry | Marked | Symmetric or asymmetric |
| PSP-RS criteria | Often atypical | Classic presentation |
| Cortical signs | Prominent early | Minimal |

Clinical Applications

Diagnostic Criteria

MRI findings support CBS diagnosis when:

• Asymmetric frontoparietal atrophy is present
• Basal ganglia atrophy is demonstrated
• Other causes of parkinsonism are excluded
• Cortical signs (apraxia, alien limb) accompany imaging findings

Prognostic Information

• Pattern of atrophy correlates with clinical phenotype
• Rate of progression may be estimated from imaging
• Conversion from CBS to CBD can be monitored
• Cognitive impairment predicts with posterior cingulate hypometabolism

Monitoring Disease Progression

• Serial MRI every 6-12 months tracks atrophy progression
• FDG-PET can monitor metabolic changes
• DTI provides sensitive white matter degeneration markers

Cross-References

• [Corticobasal Syndrome](/diseases/corticobasal-syndrome-cbs)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [FDG-PET Imaging](/imaging/fdg-pet)
• [Tau PET Imaging](/imaging/tau-pet)
• [Premotor Cortex](/brain-regions/premotor-cortex)
• [Supplementary Motor Area](/brain-regions/supplementary-motor-area)
• [Parietal Lobe](/brain-regions/parietal-lobe)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Imaging](/imaging)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

[^brain]: [Brain atrophy patterns in CBD and CBS (PMID:24291869)](https://pubmed.ncbi.nlm.nih.gov/24291869/)
[^niccoli2022]: [Niccoli et al., Diffusion MRI in CBS and PSP (2022)](https://doi.org/10.1016/j.neuroimage.2022.119123)
[^lehericy2014]: [Lehéricy et al., Functional MRI in CBS (2014)](https://doi.org/10.1212/WNL.0000000000000316)
[^boden2022]: [G. Boden et al., Tau PET in CBS (2022)](https://doi.org/10.1002/alz.056980)